On Tuesday, the blockbuster anti-inflammatory medicine Stelara’s continued popularity helped Johnson & Johnson (JNJ.N) improve its 2023 profit prediction. The…
Trending
- Amazon to spend $11bn on satellite firm in growing Starlink rivalry
- UK faces biggest hit to growth from Iran war of major economies, IMF says
- Global economy at risk of recession if Iran war persists, warns IMF
- Oil prices continue to fall on hopes of new US-Iran peace talks
- Roblox defends expanded age‑checks after parents raise concerns over errors
- Oil at $100 Again A Crisis Fueled by Conflict and Uncertainty
- Pope says he has ‘no fear’ of Trump after scathing criticism
- The End of an Era: Hungary Turns the Page on Viktor Orbán
© 2026 All right Reserved By Biznob.